«YURiA-PHARM» Corporation, traditionally, took part in the European Respiratory Society (ERS) International Congress. The largest respiratory meeting in the world took place on September 15-19 in Paris. Within 5 days over 22 thousand visitors attended the event, among them, there was a Ukrainian delegation headed by Yuriy Feshchenko, the chairman of the Association of Phthisiology and Pulmonology of Ukraine.
There was a huge number of visitors near the booth of «YURiA-PHARM».
The corporation introduced a line of combined solutions for inhalations based on sodium chloride and hyaluronic acid. Doctors from all over the world noted the perspective and affordability of the following medications: OKISTAR HYAL 7 is used for the treatment of patients with cystic fibrosis and bronchiectasis, Lorde® Hyal is indicated for patients with a cough, NASISOFT is used for nasal hygiene and the prevention and treatment of rhinitis.